Company Encyclopedia
View More
name
Large Growth
CP99102.HK
News
View More

China Greenlights World’s First Dual-Immunotherapy for Colon Cancer Ahead of Surgery

China's drug regulator has approved Innovent Biologics' Daboxin® (Ipilimumab N01 Injection) for use with another monoclonal antibody as a pre-surgery immunotherapy for colon cancer. This is the world's first approved dual-immunotherapy neoadjuvant regimen for resectable stage IIB to III MSI-H/dMMR colon cancer. The treatment aims to improve outcomes and reduce chemotherapy reliance for patients less responsive to traditional treatments.

Yicai·
HK
01801
+0.06%
Yicai·
HK
01801
+0.06%

Innovent Biologics Wins NMPA Approval for First Domestic CTLA-4 Antibody TABOSUN in Colon Cancer

Innovent Biologics Inc. has received approval from China's NMPA for TABOSUN® (ipilimumab N01 injection), the first domestic CTLA-4 monoclonal antibody, for use with TYVYT® in treating stage IIB-III MSI-H/dMMR colon cancer. This marks the first global approval for such a neoadjuvant treatment, addressing a significant unmet need in China.

Reuters·
HK
01801
+0.06%
Reuters·
HK
01801
+0.06%

Top 5 HK Stock Gainers/Losers (>100B) (12.24)

SMIC(00981) rose 3.12%, with a trading turnover 5.0 Billion HKD, and a year-to-date rose 123.4%. CHINAHONGQIAO(01378) rose 2.34%, with a trading turnover 625.9 Million HKD, and a year-to-date rose 200.9%.

Top Gainers & Losers·
HK
00981
+3.12%
HK
01378
+2.34%
HK
01816
+2.03%
Top Gainers & Losers·
HK
00981
+3.12%
HK
01378
+2.34%
HK
01816
+2.03%

‘C-beauty’ brands find retail expansion outside China a slow slog

Chinese beauty brands, including Mao Geping Cosmetics and Proya Cosmetics, face challenges in expanding internationally. Despite a strong debut in Hong Kong, Mao Geping's overseas expansion is sluggish, with plans to enter markets like Singapore and the UK. Proya aims for global presence through mergers and acquisitions. Chinese brands, smaller than Western counterparts, rely on social media for overseas growth. China's cosmetics exports rose 12% in early 2025, with Southeast Asia as a key market. Brands like Florasis and Colorkey use social media to penetrate international markets.

南华早报·
SH
603605
+0.06%
HK
01318
+1.36%
南华早报·
SH
603605
+0.06%
HK
01318
+1.36%

[Gold] As gold refreshes at 4500 USD, the upstream and downstream stocks of gold show different trends. Pay attention to the long position deployment in LAOPU GOLD 22105/ZIJIN MINING 23800

Gold prices have surpassed USD 4,500, and LAOPU GOLD's stock price has risen 176% year-to-date, but it fell 5% this morning. Investors may pay attention to LAOPU's call and put warrants. ZIJIN MINING's target price has been raised to HKD 40, and its stock price rose nearly 2% this morning, warranting attention to call warrants. Investors should be aware of the risks associated with structured products and should understand the nature and risks of the products before investing

𣾀豐輪證點評·
HK
06181
-2.67%
SH
601899
+4.68%
HK
02899
+0.98%
𣾀豐輪證點評·
HK
06181
-2.67%
SH
601899
+4.68%
HK
02899
+0.98%
Posts
View More

XD Inc.‌ 1H25 Quick Interpretation: The overall performance in the first half slightly exceeded expectations, specifically in TapTap and profitability. (The expectations in the chart are relatively la...

  • 0
© 2025 Longbridge｜Disclaimer